<DOC>
	<DOCNO>NCT00406900</DOCNO>
	<brief_summary>Uveal Melanoma common primary intraocular tumor adult . Most tumor metastasize liver . So far sensitive specific serological tumor marker routinely use . The marker `` Melanoma inhibitory activity '' promise marker . Study hypothesis detect metastatic lesion early stage . This would increase life expectance patient</brief_summary>
	<brief_title>Melanoma Inhibitory Activity ( MIA ) : A Serological Marker Metastatic Uveal Melanoma</brief_title>
	<detailed_description>Serum take melanoma patient every follow sign concent . With ELISA marker MIA evaluate . An increase MIA serum level lead search metastasis oncologist .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<criteria>uveal melanoma ( With/without overt metastatic disease )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2006</verification_date>
	<keyword>uveal melanoma</keyword>
	<keyword>metastatic disease</keyword>
</DOC>